Low RAI2 expression is a marker of poor prognosis in breast cancer

被引：0
作者：
Sayaka Nishikawa
Yasuaki Uemoto
Tae-Sun Kim
Tomoka Hisada
Naoto Kondo
Yumi Wanifuchi-Endo
Takashi Fujita
Tomoko Asano
Yusuke Katagiri
Mitsuo Terada
Akiko Kato
Yu Dong
Hiroshi Sugiura
Katsuhiro Okuda
Hiroyuki Kato
Satoshi Osaga
Satoru Takahashi
Tatsuya Toyama
机构：
[1] Nagoya City University Graduate School of Medical Sciences,Department of Breast Surgery
[2] Nagoya City University Graduate School of Medical Sciences,Advanced Medicine
[3] Nagoya City University Graduate School of Medical Sciences,Department of Oncology, Immunology and Surgery
[4] Nagoya City University Graduate School of Medical Sciences,Department of Experimental Pathology and Tumor Biology
[5] Nagoya City University Hospital,Clinical Research Management Center
[6] Toyokawa City Hospital,Department of Breast and Endocrine Surgery
来源：
Breast Cancer Research and Treatment | 2021年 / 187卷
关键词：
Breast cancer; Retinoic acid-induced 2 (RAI2); Disseminated tumor cells (DTC);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：81 / 93
页数：12
相关论文
共 50 条
  • [21] Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer
    Mark R Pickard
    Andrew R Green
    Ian O Ellis
    Carlos Caldas
    Vanessa L Hedge
    Mirna Mourtada-Maarabouni
    Gwyn T Williams
    Breast Cancer Research, 11
  • [22] LAMP1 expression is associated with poor prognosis in breast cancer
    Wang, Qingqing
    Yao, Juan
    Jin, Qin
    Wang, Xudong
    Zhu, Huijun
    Huang, Fan
    Wang, Wei
    Qiang, Jianfeng
    Ni, Qichao
    ONCOLOGY LETTERS, 2017, 14 (04) : 4729 - 4735
  • [23] Low expression of BMPRIB indicates poor prognosis of breast cancer and is insensitive to taxane-anthracycline chemotherapy
    Dai, Kun
    Qin, Fengxia
    Zhang, Huikun
    Liu, Xiaoli
    Guo, Caixia
    Zhang, Ming
    Gu, Feng
    Fu, Li
    Ma, Yongjie
    ONCOTARGET, 2016, 7 (04) : 4770 - 4784
  • [24] DHX32 expression is an indicator of poor breast cancer prognosis
    Wang, Meng
    Zhang, Guojun
    Wang, Yajie
    Ma, Ruimin
    Zhang, Limin
    Lv, Hong
    Fang, Fang
    Kang, Xixiong
    ONCOLOGY LETTERS, 2017, 13 (02) : 942 - 948
  • [25] Decreased expression of stomatin predicts poor prognosis in HER2-positive breast cancer
    Chin-Yau Chen
    Chih-Yung Yang
    Yen-Chung Chen
    Chia-Wen Shih
    Su-Shun Lo
    Chi-Hung Lin
    BMC Cancer, 16
  • [26] High BRCA2 mRNA expression predicts poor prognosis in breast cancer patients
    Egawa, C
    Miyoshi, Y
    Taguchi, T
    Tamaki, Y
    Noguchi, S
    INTERNATIONAL JOURNAL OF CANCER, 2002, 98 (06) : 879 - 882
  • [27] Soluble Neuropilin-1 is an independent marker of poor prognosis in early breast cancer
    Rachner, Tilman D.
    Kasimir-Bauer, Sabine
    Goebel, Andy
    Erdmann, Kati
    Hoffmann, Oliver
    Rauner, Martina
    Hofbauer, Lorenz C.
    Kimmig, Rainer
    Bittner, Ann-Kathrin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (08) : 2233 - 2238
  • [28] TENASCIN IN BREAST-CANCER DEVELOPMENT - IS EPITHELIAL TENASCIN A MARKER FOR POOR-PROGNOSIS
    YOSHIDA, T
    ISHIHARA, A
    HIROKAWA, Y
    KUSAKABE, M
    SAKAKURA, T
    CANCER LETTERS, 1995, 90 (01) : 65 - 73
  • [29] Soluble Neuropilin-1 is an independent marker of poor prognosis in early breast cancer
    Tilman D. Rachner
    Sabine Kasimir-Bauer
    Andy Goebel
    Kati Erdmann
    Oliver Hoffmann
    Martina Rauner
    Lorenz C. Hofbauer
    Rainer Kimmig
    Ann-Kathrin Bittner
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 2233 - 2238
  • [30] Decreased expression of stomatin predicts poor prognosis in HER2-positive breast cancer
    Chen, Chin-Yau
    Yang, Chih-Yung
    Chen, Yen-Chung
    Shih, Chia-Wen
    Lo, Su-Shun
    Lin, Chi-Hung
    BMC CANCER, 2016, 16
12345